These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10456461)

  • 21. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study.
    Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K
    Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
    Okin PM; Wachtell K; Kjeldsen SE; Julius S; Lindholm LH; Dahlöf B; Hille DA; Nieminen MS; Edelman JM; Devereux RB
    Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):337-43. PubMed ID: 19808428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-intensity anticoagulation for stroke prevention in elderly patients with atrial fibrillation: efficacy and safety in actual clinical practice.
    Ono A; Fujita T
    J Clin Neurosci; 2005 Nov; 12(8):891-4. PubMed ID: 16271478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
    Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
    J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stroke event rates in anticoagulated patients with paroxysmal atrial fibrillation.
    Lip GY; Frison L; Grind M;
    J Intern Med; 2008 Jul; 264(1):50-61. PubMed ID: 18266660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atrial fibrillation and plasma troponin I elevation after cardiac surgery: relation to inflammation-associated parameters.
    Knayzer B; Abramov D; Natalia B; Tovbin D; Ganiel A; Katz A
    J Card Surg; 2007; 22(2):117-23. PubMed ID: 17338744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
    Savelieva I; Bajpai A; Camm AJ
    Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stroke prevention in elderly patients with atrial fibrillation.
    Lew SJ; Lim JK
    Singapore Med J; 2002 Apr; 43(4):198-201. PubMed ID: 12188065
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R; Olsson SB; Lip GY; Camm AJ; Breithardt G; Capucci A; Meeder JG; Prins MH; Lévy S; Crijns HJ;
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation.
    Conway DS; Buggins P; Hughes E; Lip GY
    Am Heart J; 2004 Sep; 148(3):462-6. PubMed ID: 15389233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
    Wachtell K; Lehto M; Gerdts E; Olsen MH; Hornestam B; Dahlöf B; Ibsen H; Julius S; Kjeldsen SE; Lindholm LH; Nieminen MS; Devereux RB
    J Am Coll Cardiol; 2005 Mar; 45(5):712-9. PubMed ID: 15734615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atrial fibrillation in haemodialysis patients: do the guidelines for anticoagulation apply?
    To AC; Yehia M; Collins JF
    Nephrology (Carlton); 2007 Oct; 12(5):441-7. PubMed ID: 17803466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of congestive heart failure on plasma von Willebrand factor and soluble P-selectin concentrations in patients with non-valvar atrial fibrillation.
    Lip GY; Pearce LA; Chin BS; Conway DS; Hart RG
    Heart; 2005 Jun; 91(6):759-63. PubMed ID: 15894770
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypercoagulability and chronic atrial fibrillation: the role of markers of thrombin generation.
    Soncini M; Casazza F; Mattioli R; Bonfardeci C; Motta A; Cimminiello C
    Minerva Med; 1997 Dec; 88(12):501-5. PubMed ID: 9540779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prevention of thromboembolism in patients with atrial fibrillation].
    Veselka J; Bartůnĕk P
    Vnitr Lek; 1996 Nov; 42(11):792-5. PubMed ID: 9012126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Underutilization of warfarin in older persons with chronic nonvalvular atrial fibrillation at high risk for developing stroke.
    Mendelson G; Aronow WS
    J Am Geriatr Soc; 1998 Nov; 46(11):1423-4. PubMed ID: 9809766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of deep vein thrombosis after extensive abdominal operations by the quotient between plasmin-alpha 2-antiplasmin complex and fibrinogen concentration in plasma.
    Mellbring G; Dahlgren S; Wiman B
    Surg Gynecol Obstet; 1985 Oct; 161(4):339-42. PubMed ID: 2413560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation.
    Tóth NK; Csanádi Z; Hajas O; Kiss A; Nagy-Baló E; Kovács KB; Sarkady F; Muszbek L; Bereczky Z; Csiba L; Bagoly Z
    Biomed Res Int; 2017; 2017():3678017. PubMed ID: 28713823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atrial fibrillation and embolic complications.
    Maru M
    East Afr Med J; 1997 Jan; 74(1):3-5. PubMed ID: 9145567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.